dicyclomine hydrochloride capsule
bryant ranch prepack - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul
dicyclomine hydrochloride capsule dicyclomine hydrochloride tablet
a-s medication solutions - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul
dicyclomine hydrochloride capsule dicyclomine hydrochloride tablet
a-s medication solutions - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul
dicyclomine hydrochloride capsule dicyclomine hydrochloride tablet
rpk pharmaceuticals, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] , and in patients with: - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions (5.4)] - glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] - obstructive uropathy [see warnings and precautions (5.8)] - obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] - severe ulcerative colitis [see warnings and precautions (5.7)] - reflux esophagitis teratogenic effects: pregnancy category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malform
jamp-dicyclomine hcl tablet
jamp pharma corporation - dicyclomine hydrochloride - tablet - 20mg - dicyclomine hydrochloride 20mg - antimuscarinics antispasmodics
jamp-dicyclomine hcl tablet
jamp pharma corporation - dicyclomine hydrochloride - tablet - 10mg - dicyclomine hydrochloride 10mg - antimuscarinics antispasmodics
dicyclomine hydrochloride capsule
physicians total care, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride tablets and capsules are indicated for the treatment of functional bowel/ irritable bowel syndrome. - obstructive uropathy - obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions ) - reflux esophagitis - unstable cardiovascular status in acute hemorrhage - glaucoma - myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients. ) - nursing mothers (see warnings and precautions: information for patients .) abuse of and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.
dicyclomine hydrochloride capsule
tya pharmaceuticals - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age , nursing mothers , and in patients with: [see use in specific populations ( )] 8.4 [see use in specific populations ( )] 8.3 - unstable cardiovascular status in acute hemorrhage - myasthenia gravis [see warnings and precautions ( )] 5.4 - glaucoma [see adverse reactions ( ) and drug interactions ( )] 6.37.1 - obstructive uropathy [see warnings and precautions ( )] 5.8 - obstructive disease of the gastrointestinal tract [see warnings and precautions ( )] 5.
dicyclomine hydrochloride- dicyclomine hydrochloride tablet dicyclomine hydrochloride- dicyclomine hydrochloride capsule
bryant ranch prepack - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)] , nursing mothers [see use in specific populations (8.3)] and in patients with: adequate and well-controlled studies have not been conducted with dicyclomine in pregnant women at the recommended doses of 80 mg/day to 160 mg/day. however, epidemiologic studies did not show an increased risk of structural malformations among babies born to women who took products containing dicyclomine hydrochloride at doses up to 40 mg/day during the first trimester of pregnancy. reproduction studies have been performed in rats and rabbits at doses up to 33 times the maximum recommended human dose based on 160 mg/day (3 mg/kg) and have revealed no evidence of harm to the fetus due to dicyclomine. because animal reproduction studies are not always predictive of human response, this drug shoul
dicyclomine- dicyclomine hydrochloride tablet
redpharm drug, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride tablets, usp are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific populations (8.4)], nursing mothers [see use in specific populations (8.3)] and in patients with: • unstable cardiovascular status in acute hemorrhage • myasthenia gravis [see warnings and precautions (5.4)] • glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] • obstructive uropathy [see warnings and precautions (5.8)] • obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] • severe ulcerative colitis [see warnings and precautions (5.7)] • reflux esophagitis p r e g n a n c y category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show an increased